RARA and cancer: Retinoic acid receptor γ (RARG), which is 90% homologous to retinoic acid receptor α (RARA) and retinoic acid receptor β (RARB), is unique among the three RAR subtypes because it typically resides in the cytoplasm of cancer cells (9).